Checkmate Pharmaceuticals (CMPI) Financials

$10.50

$0.00 (0.00%)

As on 09-Jun-2022 09:30EDT

Market cap

$231 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	63.18	61.47	36.90	28.89	20.99	--
Operating Profit (EBIT)	-63.18	-61.47	-36.90	-28.89	-20.99	--
Other Income	0.02	--	--	--	--	--
Profit before Tax	-63.14	-61.41	-36.91	-28.29	-20.81	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-63.14	-61.41	-36.91	-28.29	-20.81	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-63.14	-61.41	-42.91	-35.04	-25.13	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	55.00	69.46	125.20	-0.51	9.17	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	11.94	9.38	7.88	5.63	3.32	--
Total Liabilities	78.89	78.84	133.07	5.13	12.49	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	4.83	4.88	30.97	--	--	--
Current Assets	62.11	73.96	102.10	5.13	12.49	--
Total Assets	78.89	78.84	133.07	5.13	12.49	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	50.17	64.58	94.23	-0.51	9.17	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-53.72	-38.11	-26.85	-20.42	--
Cash Flow from Investing Activities	--	61.19	-83.29	-83.29	-83.29	--
Cash from Financing Activities	--	0.15	160.27	18.98	10.93	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-2.87	-2.79	-3.69	-28.29	--	--
Cash EPS ($)	--	-2.79	-3.69	-28.29	--	--
Adjusted Book Value ($)	--	3.16	12.52	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.44	-3.81	-26.85	--	--
Free Cash Flow per Share ($)	--	-2.44	-3.81	-26.85	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-63.09	-59.20	-653.09	--	--
ROE (%)	-92.50	-63.09	-59.20	-653.09	--	--
ROA (%)	-61.33	-57.95	-53.41	-321.14	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-332,336.84	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-44.48	-66.57	-27.74	-37.61	--	--
Net Profit Growth (%)	-46.05	-66.37	-30.45	-35.93	--	--
EPS Growth (%)	73.39	0.24	0.87	--	--	--
Book Value Growth (%)	-51.06	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-1.03	-3.95	--	--	--
Price / Book Value	4.19	0.91	1.17	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.26	0.13	-1.39	--	--	--
Close Price ($)	3.19	2.87	14.59	--	--	--
High Price ($)	12.73	17.85	23.10	--	--	--
Low Price ($)	2.00	2.62	8.61	--	--	--
Market Cap ($ Cr)	231.40	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	5.20	7.89	12.97	0.91	3.76	--
Quick Ratio	5.20	--	--	--	--	--
Interest Coverage	-3,322.37	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.